Greenberg Traurig Hosts “Trends in Healthcare Investment” Panel

Share Article

Greenberg Traurig, LLP’s Boston office will sponsor and host a panel discussion, “Trends in Healthcare Investment,” co-organized by the Bayhelix Group and Boston Chinese Investment Club (BCIC).

Today, Greenberg Traurig, LLP’s Boston office will sponsor and host a panel discussion, “Trends in Healthcare Investment,” co-organized by the Bayhelix Group and Boston Chinese Investment Club (BCIC).

Dr. Fang Xie, Greenberg Traurig shareholder and co-leader of the firm’s Biotechnology and Pharmaceutical Industry Group of the global Life Sciences & Medical Technology Group, will welcome guests and provide opening remarks. Boston Corporate Shareholder Bradley A. Jacobson will serve as moderator. Panelists include Bihua Chen, Founder, CEO and Portfolio Manager of Cormorant Asset Management, LLC; Wei Li, Ph.D., Founding & Managing Partner of 6 Dimensions Capital, Founding Partner of WuXi Healthcare Ventures; and Jake Xia, Managing Director and Chief Risk Officer of Harvard Management Company, Inc.

Bayhelix Group is a nonprofit organization of leaders of Chinese heritage in the global life sciences and healthcare community. They aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience.

The Boston Chinese Investment Club (BCIC) is a 20-year history nonprofit organization, formerly TCFA (The Chinese Finance Association) Boston. It serves as a Boston-centered platform for exchanging ideas, knowledge, and information in finance and related areas between U.S. and China.

About Greenberg Traurig’s Life Sciences & Medical Technology Group

Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. As part of the group, the Biotechnology and Pharmaceutical Industry Group focuses on advising clients in the biotechnology and pharmaceutical sectors.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2017 Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez

+1 212-801-2131
Email >
@GT_Law
Follow >
Visit website